Knee osteoarthritis (OA) is a major cause of chronic musculoskeletal pain (Peat et al. 2001) and a leading cause of functional disability in the elderly ([@CIT0006]). Due to demographic changes, the burden of symptomatic OA is expected to increase rapidly in the future ([@CIT0008]), which highlights the need for early-stage nonoperative treatment strategies, with the potential to reverse or prevent further progression of the disease ([@CIT0009]).

While pain and functional disability are the hallmark symptoms of knee OA, radiographic characteristics are often used to characterize the severity of the disease. Since several tissue structures are potential sources of pain ([@CIT0004], [@CIT0018]), a key question is the extent to which the radiographic severity can predict the clinical result of nonoperative treatment. In other words, which treatment should be recommended for a specific level of radiographic severity, and is nonoperative treatment equally effective for different levels of radiographic severity?

In spite of the fact that the discrepancy between symptoms and radiographic severity is well described ([@CIT0001]), only 2 previous studies have addressed this issue in patients with knee OA ([@CIT0024], [@CIT0010]). One meta-regression analysis found similar effects of exercise on symptoms at all levels of radiographic severity ([@CIT0010]). Another study found that patients with the most advanced radiographic severity were less likely to report a reduction in symptoms after intraarticular injection of hyaluronic acid ([@CIT0024]). Whether these conflicting results are due to the different nature and effects of the 2 treatments on knee OA symptoms or to other factors is unknown. This calls for further analysis of the mediating effects of radiographic severity on the effects of nonoperative treatment. Such knowledge would help guide clinicians in their decision on referral to nonoperative treatment in both primary and secondary care.

The main purpose of this study was to investigate whether radiographic severity is associated with improvements in pain after nonoperative treatments in patients with knee OA who are not eligible for a total knee arthroplasty (TKA). The secondary purpose was to investigate whether various nonoperative treatments may be associated with improvements in pain. We hypothesized that radiographic severity of OA is inversely associated with self-reported improvements, and that all forms of treatment would result in larger improvement in pain than no treatment.

Patients and methods {#ss1}
====================

Study design {#ss2}
------------

This was a retrospective cohort study conforming to the STROBE statement for reporting of observational studies (von [@CIT0023]).

Participants {#ss3}
------------

2,262 consecutive patients with knee OA who were deemed not eligible for a TKA by an experienced orthopedic surgeon in the Northern Health Care Region, Denmark, between June 21, 2005 and February 2, 2012 were identified through the National Patient Registry. All the patients were then contacted by regular post 1--5 years after their initial consultation and asked to complete a follow-up questionnaire concerning their knee pain.

Patients with a previous ipsilateral knee arthroplasty, patients who underwent a surgical procedure of their knee (TKA or other surgery) during the follow-up period, and patients who had died or were unable to answer due to illness were excluded from the study. We decided not to include those who had undergone surgery as nonoperative treatment failures, since undergoing surgery does not necessarily mean that the original nonoperative treatment was unsuccessful and since the questionnaire was designed to evaluate nonoperative treatment only. So there was a risk of introducing uncertainties in the analysis if we included those who underwent surgery.

Follow-up questionnaire {#ss4}
-----------------------

The questionnaire contained questions on treatment type, improvements in pain, and the patient's opinion concerning their knee and associated problems.

Primary outcome: improvements in pain {#ss5}
-------------------------------------

Changes in knee pain after the treatment were assessed using a 4-point scale ("Pain-free", "Better", "Unchanged", or "Worse") in response to the question: "Has your pain improved?". The results were dichotomized into Improved ("Pain-free" and "Better") and Not improved ("Unchanged" and "Worse") in the statistical analyses.

Treatment type {#ss6}
--------------

Treatment type was assessed using the question "Which treatment did you receive after your initial consultation at the hospital?" with "Physiotherapy", "Pain killers", "Injection", and "Others" being the possible answers. If the participant chose "Other", he/she was asked to state which treatment was received. The participants were allowed to tick more than one box when appropriate.

Patients' opinion concerning their knee and associated problems {#ss7}
---------------------------------------------------------------

This was assessed using the knee injury and osteoarthritis outcome score (KOOS), which consists of the 5 subscales "Pain", "Other symptoms", "Function in activities of daily living (ADL)", "Function in sports and recreation (Sport/Rec)", and "Knee-related quality of life (QOL)" ([@CIT0017], [@CIT0016]).

Other measures {#ss8}
--------------

*Radiographic severity* was graded by one of the authors (CAD) using the original Kellgren-Lawrence (K&L) scale ([@CIT0011]). The reliability (Cohen's kappa) of this grading was assessed for 33 of the participants, and this showed acceptable reliability with an intra-tester reliability of 0.82 (adjusted agreement of 88%) and an inter-tester reliability of 0.91 (adjusted agreement of 94%) compared to an experienced high-volume orthopedic surgeon evaluating K&L scores daily (OS).

*Body mass index (BMI)* was registered by a nurse at the consultation with the orthopedic surgeon (not routinely). BMIs were divided into 3 groups in the statistical analyses (≤ 24.9, 25.0--29.9, and ≥ 30.0).

Statistics {#ss9}
----------

*Primary analysis*

We used logistic regression analysis and analysis of variance (ANOVA; to test the significance of each independent variable as a whole) to assess the association between improvements in pain following nonoperative treatment (Improved/Not improved) and radiographic severity adjusted for treatment type, age, sex, and BMI. We considered age as a continuous variable, and sex, treatment type, radiographic severity (K&L), and BMI as categorical variables.

We performed logistic regression analyses and ANOVAs with the following explanatory variables (5 models): (1) Main effect: K&L. (2) Main effects: K&L, age, sex, and treatment type. (3) Main effects: K&L, age, sex, BMI, and treatment type. (4) Main effects: K&L, age, sex, and treatment type. Pairwise interaction between K&L and each of the 3 other independent variables (age, sex, and treatment type). (5) Main effects: K&L, age, sex, BMI, and treatment type. Pairwise interaction between K&L and each of the 4 other independent variables (age, sex, BMI, and treatment type).

*Secondary analyses*

Additionally, the models were used to assess whether improvements in pain (Improved/Not improved) were associated with treatment type (No treatment, Physiotherapy, Pain killers, Injection, Other nonoperative, Two or more nonoperative).

KOOS was used to describe the population at follow-up and to compare those who had improvement in pain after nonoperative treatment to those who had not improved, using ANOVA. Post hoc Welch 2-sample t-tests were used to test for differences in each KOOS subscale.

We performed a non-responder analysis based on age (Welch 2-sample t-test) and sex (Fisher's exact test) in patients who responded to the follow-up questionnaire, comparing those with complete data to those who did not have complete data.

Odds ratios (ORs) were used to assess whether each of the explanatory variables was associated with improvements in pain. We used 1% as the level of statistical significance and R statistical software version 3.1.1 to perform the analyses ([@CIT0014]).

Ethics and registration {#ss10}
-----------------------

According to the National Committee on Health Research Ethics in Denmark, ethical approval was not needed. The study was conducted in accordance with the Declaration of Helsinki. It was registered at ClinicalTrial.gov (NCT02091830).

Results {#ss11}
=======

Participants {#ss12}
------------

414 patients (22%) were excluded for various reasons. Of the 1,493 patients who were eligible for the study, 1,414 (95%) responded to the questionnaire with complete data on improvement in pain and treatment type, with knee radiographs available from their consultation with the orthopedic surgeon. Of the 1,414 participants, BMI was available for 910 (64%) ([Figure 1](#F1){ref-type="fig"}).

![Flow chart of patients.](ORT-86-599-g001){#F1}

Apart from physiotherapy, pain killers, and injections, knee orthoses and foot orthoses were some of the most frequently used nonoperative treatments ([Table 1](#T1){ref-type="table"}). At follow-up, the mean KOOS values (with range) for all 1,414 participants were 64 (0--100), 68 (7--100), 66 (0--100), 37 (0--100), and 46 (0--100) for the subscales Pain, Symptoms, ADL, Sport/Rec, and QOL, respectively.

###### 

Descriptive data on the participants[^a^](#fnaa){ref-type="fn"}

  Parameter                       All participants (n = 1,414)   Participants with known BMI (n = 910)
  ------------------------------- ------------------------------ ---------------------------------------
  Women, n (%)                    771 (55)                       506 (56)
  Age in years, mean (range)      66 (24--96)                    67 (34--96)
  Radiographic severity, n (%)                                   
   Grade 0                        52 (3.7)                       28 (3.1)
   Grade 1                        101 (7.1)                      69 (7.6)
   Grade 2                        93 (6.6)                       52 (5.7)
   Grade 3                        633 (45)                       409 (45)
   Grade 4                        535 (38)                       352 (39)
  Body mass index, mean (range)   --                             29 (17--54)
  Body mass index, n (%)                                         
   ≤ 24.9                         --                             197 (23)
   25--29.9                       --                             396 (44)
   ≥ 30                           --                             317 (35)
  Treatment type, n (%)                                          
   None                           836 (59)                       483 (53)
   Physiotherapy                  146 (10)                       126 (14)
   Pain killers                   129 (9.1)                      86 (9.5)
   Injection                      136 (9.6)                      87 (9.6)
   Other nonoperative             69 (4.9)                       45 (5.0)
   2 or more nonoperative         98 (6.9)                       83 (9.1)
  Pain improved, n (%)                                           
   No                             766 (54)                       466 (51)
   Yes                            648 (46)                       444 (49)

**^a^**Radiographic severity: severity of radiographic knee osteoarthritis on the Kellgren-Lawrence scale.

Primary analysis {#ss13}
----------------

There was no association between radiographic severity and self-reported improvement in pain. When we adjusted for type of treatment, sex and age---and also the same variables and BMI---this did not change the estimates, showing that there was no association between radiographic severity and self-reported improvement in pain ([Table 2](#T2){ref-type="table"}).

###### 

Results from the logistic regression analyses. Outcome: improvement in pain

  Model (main effects)                                        Odds ratio[^a^](#fna){ref-type="fn"}   p-value[^b^](#fn2b){ref-type="fn"}   95% CI of odds ratio   
  ----------------------------------------------------------- -------------------------------------- ------------------------------------ ---------------------- --
  Model 1 (K&L; n = 1,414)                                                                                                                                       
   Reference category (K&L 0)                                                                        0.2                                                         
   K&L 1                                                      1.5                                    0.3                                  0.74--2.9              
   K&L 2                                                      1.2                                    0.7                                  0.59--2.3              
   K&L 3                                                      1.4                                    0.2                                  0.81--2.6              
   K&L 4                                                      1.1                                    0.8                                  0.60--1.9              
  Model 2 (K&L, age, sex, and treatment type; n = 1,414)                                                                                                         
   Reference category[^c^](#fn2c){ref-type="fn"}                                                     \< 0.001                                                    
   K&L 1                                                      1.3                                    0.4                                  0.66--2.7              
   K&L 2                                                      1.0                                    1.0                                  0.50--2.0              
   K&L 3                                                      1.2                                    0.6                                  0.65--2.1              
   K&L 4                                                      0.82                                   0.5                                  0.45--1.5              
   Age (1 year older)                                         1.02                                   \< 0.001                             1.01--1.03             
   Male                                                       1.0                                    0.8                                  0.83--1.3              
   Treatment                                                                                                                                                     
    physiotherapy                                             2.5                                    \< 0.001                             1.6--3.4               
    pain killers                                              1.5                                    0.04                                 1.0--2.2               
   injection                                                  1.6                                    0.02                                 1.1--2.3               
    other nonoperative                                        1.3                                    0.4                                  0.76--2.1              
    2 or more nonoperative                                    2.1                                    \< 0.001                             1.4--3.3               
  Model 3 (K&L, age, sex, BMI, and treatment type; n = 910)                                                                                                      
   Reference category**[^d^](#fn2d){ref-type="fn"}**                                                 \< 0.001                                                    
   K&L 1                                                      1.8                                    0.3                                  0.71--4.5              
   K&L 2                                                      1.0                                    1.0                                  0.39--2.7              
   K&L 3                                                      1.4                                    0.4                                  0.63--3.2              
   K&L 4                                                      1.1                                    0.8                                  0.49--2.6              
   Age (1 year older)                                         1.02                                   \< 0.001                             1.01--1.04             
   Male                                                       1.0                                    1.0                                  0.77--1.3              
   BMI 25--29.9                                               0.80                                   0.2                                  0.56--1.1              
   BMI ≥ 30                                                   0.81                                   0.3                                  0.56--1.2              
   Treatment                                                                                                                                                     
    physiotherapy                                             2.4                                    \< 0.001                             1.6--3.6               
    pain killers                                              1.6                                    0.06                                 0.99--2.5              
    injection                                                 1.5                                    0.08                                 0.95--2.4              
    other nonoperative                                        1.3                                    0.4                                  0.68--2.4              
    2 or more nonoperative                                    2.2                                    0.001                                1.4--3.6               

**^a^**Odds ratio of having improved pain (improved vs. not improved) with the effect compared to the reference category. For example, an effect size of 1.50 for Kellgren-Lawrence grade 1 (K&L 1) would mean that the odds ratio of improved pain if having K&L 1 instead of K&L 0 would be 1.50.

**^b^**p-value of odds ratio; p-values less than 0.01 were considered statistically significant.

**^c^**Reference category: (K&L 0, 0 years, woman, no treatment).

**^d^**Reference category: (K&L 0, 0 years, woman, BMI ≤ 24.9, no treatment).

When we included the predefined interactions in the analysis (models 4 and 5), similar estimates were found and no significant interactions were apparent (data not shown).

Secondary analyses {#ss14}
------------------

Compared to no treatment, physiotherapy (OR = 2.4 and 2.4) and 2 or more nonoperative treatments (OR = 2.1 and 2.2) were significantly associated with improvement in pain when we adjusted for radiographic severity, age, and sex---and when we adjusted for the same variables and BMI ([Table 2](#T2){ref-type="table"}).

Mean KOOS values for the 648 participants with improved pain were significantly higher than for the 766 participants without improvement in pain following nonoperative treatment (p \< 0.001). Mean differences (with 95% confidence interval (CI)) in KOOS subscale scores were 24 (22--6) for Pain, 20 (18--22) for Symptoms, 22 (20--24) for ADL, 24 (22--27) for Sport/Rec, and 25 (23--27) for QOL ([Figure 2](#F2){ref-type="fig"}).

![The mean subscale values from KOOS for participants with improvement in pain (n = 648) and those with no improvement in pain (n = 766). Error bars indicate 95% confidence intervals. The 2 groups were significantly different for all subscales (p \< 0.0001).](ORT-86-599-g002){#F2}

Non-responder analysis {#ss15}
----------------------

The 79 participants with incomplete data were older (mean difference 6.6 years (95% CI: 3.9--9.4)), but had similar sex distribution (p = 0.30) to the 1,414 participants examined in the primary and secondary analyses.

Discussion {#ss16}
==========

We found that radiographic severity was not associated with improvement in pain after nonoperative treatment in patients with knee OA. This was also true after adjusting for known confounders and the type of treatment the patient received. Our findings confirm a recent meta-analysis demonstrating that physiotherapy (exercise) has similar effects on symptoms irrespective of the level of radiographic severity ([@CIT0010]). This shows that the orthopedic surgeon can confidently refer a patient with severe radiographic knee OA for nonoperative treatment to improve symptoms.

Since knee OA is known to progress ([@CIT0022]), and since the prevalence of knee OA can be expected to increase substantially in the future ([@CIT0007]), early treatment strategies could be important to reduce the disease burden in the future by preventing (or even reversing) progression of the disease ([@CIT0009]). Physiotherapy (exercise and patient education) in combination with weight loss (if needed) is recommended as the core treatment of knee and hip OA in evidence-based guidelines ([@CIT0005], [@CIT0012]). Our study supports this, by demonstrating that nonoperative treatment (physiotherapy and a combined treatment) is associated with improvements in symptomatic knee OA. Since the diagnosis of knee OA can be given on a clinical basis ([@CIT0025]), and since only 0.5% of radiographs reveal pathology needing specific treatment (osteonecrosis, osteochondral lesion, fracture, and subluxation) ([@CIT0020]), nonoperative treatment can be initiated regardless of the availability or severity of a radiograph.

Surprisingly, in our study only 41% of patients with knee OA who were found not to be eligible for a TKA by an orthopedic surgeon received nonoperative treatment within 1--5 years after the consultation, and only 10% received physiotherapy. Considering that the KOOS scores for the 5 subscales were up to 30 points lower than reference values from a population-based cohort with adults of similar age ([@CIT0013]), it appears unlikely that the reason for this lack of treatment was that the patients had less severe symptoms of knee OA. It is well known that clinical practice does not reflect all recommendations of guidelines ([@CIT0002], [@CIT0021], [@CIT0003]). A recent study showed results similar to ours, demonstrating that only 10% of patients who received a TKA had undergone physiotherapy specifically for their knee OA in the preceding 5 years ([@CIT0003]). Based on the small proportion that received nonoperative treatment, it was not surprising that only half felt that their pain had improved since their consultation with the orthopedic surgeon. Given the results of our study, improvement of adherence to the guidelines has the potential to improve pain in a higher proportion of patients with knee OA; introducing a nationwide initiative comprising physiotherapist-led exercise and education could be a way of accomplishing this ([@CIT0019]).

Some limitations of the study should be considered. First of all, BMI was not available for all the participants. However, the analysis with adjustment for BMI showed similar results to the analysis without adjustment for BMI. Secondly, regression towards the mean could influence the improvements found from treatment. However, as the odds of improvements were higher in patients who received physiotherapy or multimodal treatments than in patients who had no treatment (serving as a control group), regression towards the mean appears less important. Furthermore, the assessment of improvement in pain was done using an unvalidated scale, which could be regarded as a limitation. However, statistically significant differences were found between those whose pain improved and those whose pain did not improve, in all KOOS subscales---a reliable, validated, and responsive outcome measure ([@CIT0015]). This supports the validity of the results from the primary analysis. Another limitation of the study was the lack of information on what the physiotherapy involved. Since the effects of physiotherapy-related treatments are known to vary ([@CIT0012]), the effect of physiotherapy found in our study represents an average of the effects of different treatments---both treatments known to be effective (e.g. exercise and education) and treatments of uncertain effectiveness (e.g. ultrasound) ([@CIT0012]). Thus, the treatment of knee OA with exercise and education as recommended in clinical guidelines ([@CIT0005], [@CIT0012]) is likely to result in an even better chance of improvement in pain than was demonstrated in our study.

To summarize, the level of radiographic severity was not associated with improvement in pain after nonoperative treatment. In patients who are not eligible for TKA, the orthopedic surgeon can confidently refer patients for nonoperative treatment even in severe radiographic knee OA and in patients with high BMI. The treatment should preferably be a combined treatment including physiotherapy, as recommended in clinical guidelines.
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